Home / Investors / Startups / Prellis Biologics

Prellis Biologics

Prellis employs holographic tissue printing technology with rapid fully human antibody discovery, in vitro human disease and ADME/Tox models

About Prellis Biologics

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.

Industries

Investors in Prellis Biologics (5)